These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425 [TBL] [Abstract][Full Text] [Related]
8. A role for matrix remodelling proteins in invasive and malignant meningiomas. Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma. Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122 [TBL] [Abstract][Full Text] [Related]
10. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408 [TBL] [Abstract][Full Text] [Related]
11. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Trinkaus M; Vranic A; Dolenc VV; Lah TT Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773 [TBL] [Abstract][Full Text] [Related]
12. SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. Zhang Y; Yu R; Li Q; Li Y; Xuan T; Cao S; Zheng J J Cell Biochem; 2020 Feb; 121(2):1880-1889. PubMed ID: 31692066 [TBL] [Abstract][Full Text] [Related]
13. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530 [TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400 [TBL] [Abstract][Full Text] [Related]
15. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
17. Meningioma: current updates on genetics, classification, and mouse modeling. Szulzewsky F; Thirimanne HN; Holland EC Ups J Med Sci; 2024; 129():. PubMed ID: 38571886 [TBL] [Abstract][Full Text] [Related]
18. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067 [TBL] [Abstract][Full Text] [Related]
19. Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development. Najm P; Zhao P; Steklov M; Sewduth RN; Baietti MF; Pandolfi S; Criem N; Lechat B; Maia TM; Van Haver D; Corthout N; Eyckerman S; Impens F; Sablina AA Cancer Res; 2021 Aug; 81(16):4218-4229. PubMed ID: 34215617 [TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]